Is Wegovy Covered by Insurance? Which Plans Pay and How to Get Approved

Wegovy is covered by some commercial insurance plans, usually with prior authorization, but many employer plans still exclude weight-loss drugs. In KFF’s 2025 survey, 19% of large employers covered GLP-1s like Wegovy for weight loss, rising to 43% of employers with 5,000 or more workers. With coverage and the Wegovy Savings Card, you can pay as little as $25 a month; without it, the list price is about $1,349 a month, NovoCare’s self-pay price is $349 for the pen and $149 to $299 for the pill, and eligible Medicare Part D members pay $50 through the Medicare GLP-1 Bridge.

Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk. The FDA approved it in June 2021 specifically for chronic weight management — making it one of the first GLP-1 receptor agonists with an explicit obesity indication rather than just a diabetes label.

The coverage question is more complicated than it should be. Whether your insurance covers Wegovy depends on three things: the type of insurance you have (commercial vs government), whether your plan’s formulary includes GLP-1 medications for weight loss, and whether you meet the prior authorization criteria your insurer sets. Each of those layers can block access even when the drug is medically appropriate.

Sometimes. Wegovy is covered by insurance when your plan includes weight-loss drugs on its formulary and you meet prior authorization criteria, usually a BMI of 30 or higher, or 27 with a weight-related condition. Many employer plans still exclude anti-obesity drugs. Medicare covers Wegovy under Part D for cardiovascular risk reduction, and since July 1, 2026 eligible beneficiaries can get it for weight management at $50 a month through the Medicare GLP-1 Bridge program.

Is Wegovy Covered by Insurance?

If your commercial plan covers it, the Wegovy Savings Card can bring the cost down to as little as $25 a month. If it doesn’t, NovoCare Pharmacy sells the Wegovy pen to self-pay patients for $349 a month at maintenance doses and $399 for Wegovy HD, and the Wegovy pill starts at $149. The list price is about $1,349 a month.

Prior authorization is where most people get stuck. Expect the plan to ask for your BMI, your weight-related diagnoses and proof of a prior weight-loss attempt, then to re-check your progress after about six months.

Sources: NovoCare, Wegovy coverage and Medicare GLP-1 Bridge; Drugs.com (August 2026). Prices change often; confirm before filling.

Is the Wegovy Pill Covered by Insurance?

The Wegovy pill (oral semaglutide), approved by the FDA in December 2025 and launched in January 2026, is covered the same way as the injection: only if your plan covers anti-obesity drugs, and usually with prior authorization. If your plan covers it, the Wegovy Savings Card applies to the pill too.

Self-pay prices are Novo Nordisk’s published NovoCare Pharmacy prices as of September 2026 and change often; confirm at NovoCare before ordering. The Medicare GLP-1 Bridge runs July 1, 2026 through December 31, 2027 for Part D enrollees who meet CMS criteria. The Savings Card is not available with Medicare, Medicaid or other government coverage.

Because the pill is new, some plans haven’t added it to their formulary even when they cover the injection. If your plan covers the pen but not the pill, your doctor can request a formulary exception or prescribe the covered form.

Which Insurance Plans Cover Wegovy?

Commercial (Employer-Sponsored) Insurance

Coverage is expanding but far from universal, and it depends heavily on employer size. In KFF’s 2025 Employer Health Benefits Survey, 16% of firms with 200 to 999 workers, 30% of firms with 1,000 to 4,999 workers and 43% of firms with 5,000 or more workers covered GLP-1s used primarily for weight loss. The trend is clearly upward — driven by employer interest in reducing downstream healthcare costs from obesity-related conditions like diabetes, cardiovascular disease, and joint problems. Self-funded employers pay that cost directly through claims, so many are moving to managed access instead of open coverage, an approach we break down in GLP-1 coverage for self-funded employers in 2027.

When covered, Wegovy typically sits on Tier 3 or Tier 4 (specialty tier) of the formulary. That means higher copays than generic drugs, which vary widely by plan, and almost always a prior authorization requirement. The Wegovy Savings Card can offset much of that copay for eligible commercially insured patients. Your doctor will need to document your BMI, prior weight-loss attempts, and comorbidities before the plan approves the prescription.

Plans that don’t cover Wegovy often have a blanket exclusion for “weight loss medications” or “anti-obesity drugs” in the benefit summary. Check your Summary Plan Description (SPD) or call the number on your insurance card and ask specifically about GLP-1 coverage for obesity.

ACA Marketplace Plans

Coverage varies by state and by plan. ACA plans are not required to cover weight loss medications under the essential health benefits mandate. Some state-based marketplace plans do include GLP-1 coverage; many don’t. Check your specific plan’s formulary before assuming coverage.

Medicare Part D

Standard Medicare Part D plans do not cover Wegovy when prescribed for weight loss, but since July 1, 2026 eligible beneficiaries can get it for weight management at $50 a month through the Medicare GLP-1 Bridge program. Section 1862(a)(1)(A) of the Social Security Act excludes drugs used for “anorexia, weight loss, or weight gain” from Part D coverage. This applies to all Medicare Part D plans, including Medicare Advantage plans with integrated Part D.

There is one exception: if Wegovy is prescribed for a covered indication other than weight loss (the drug has a separate FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and BMI ≥27), some Medicare plans may cover it under that indication. Your doctor would need to prescribe it specifically for cardiovascular risk reduction, not weight management.

Dental expenses illustrate the out-of-pocket gap — our breakdown of dental cleaning costs without insurance shows what patients actually pay when preventive coverage is missing, and the same gap applies to chiropractor visits and MRI scans.

When Wegovy coverage is denied, patients often pivot to tirzepatide — Mounjaro costs without insurance including deductibles details the full out-of-pocket cost structure for Mounjaro without any plan assistance.

Congressional legislation to allow Medicare coverage of weight loss drugs has been introduced repeatedly but has not passed as of May 2026.

Medicaid

Coverage varies by state. Most state Medicaid programs do not cover weight loss medications, though a growing number are adding GLP-1 coverage as the cost-effectiveness data improves. Check your state’s Medicaid formulary.

How Much Does Wegovy Cost Without Insurance?

Very few people pay the full list price. Here’s what each route costs per month and per year, based on Novo Nordisk’s published pricing as of September 2026.

How Do You Know If Your Insurance Covers Wegovy?

The fastest answer comes from your pharmacy benefit, not your medical plan. Four checks settle it in a day or two.

• Use the coverage checker: Novo Nordisk’s coverage checker on wegovy.com looks up your plan from your insurance card.
• Call the pharmacy benefits number: Ask whether semaglutide (Wegovy pen and pill) is covered for chronic weight management, what tier it sits on, and whether prior authorization or step therapy applies.
• Read the plan documents: Look for “anti-obesity medications” or “weight-loss drugs” in the exclusions section of your Summary Plan Description.
• Ask HR: Employer plans decide whether to cover weight-loss drugs, so your benefits team can confirm the rule and any lifestyle-program requirement.
• Check the indication: Some plans that exclude weight loss still cover Wegovy to reduce cardiovascular risk in adults with established heart disease and obesity or overweight.

What Can You Do If Insurance Won’t Cover Wegovy?

A denial isn’t always final. Ask for the reason in writing, have your doctor appeal or request a peer-to-peer review, and ask whether a formulary exception is possible. If the plan excludes weight-loss drugs entirely, compare NovoCare self-pay, the Medicare GLP-1 Bridge if you’re eligible, and alternatives your doctor considers appropriate.

How To Get Wegovy Covered by Insurance

If your plan covers GLP-1 medications for weight management, here’s the process:

• Confirm formulary coverage: Call the pharmacy benefits number on your insurance card. Ask specifically: “Does my plan cover semaglutide (Wegovy) for weight management?” Get the answer in writing if possible.
• Meet prior authorization criteria: Most plans require documented BMI ≥30 (or ≥27 with comorbidities), evidence of prior weight-loss attempts (diet, exercise, sometimes previous medications), and a prescribing physician who documents medical necessity.
• Have your doctor submit the PA: The prescribing physician’s office submits the prior authorization to your insurer with supporting documentation. Turnaround is typically 3-10 business days.
• Appeal if denied: First-level denials are common and don’t always mean final “no.” A peer-to-peer review between your doctor and the insurer’s medical director overturns many initial denials. Request the specific denial reason in writing.
• Use step therapy if required: Some plans require you to try (and fail) a less expensive weight-loss medication before approving Wegovy. Completing the step therapy requirement — even if the prior medication didn’t work well — satisfies the coverage criteria.

Wegovy Savings Card and Patient Assistance

Novo Nordisk offers a manufacturer savings program that can reduce your out-of-pocket cost dramatically:

• Wegovy Savings Card: For commercially insured patients whose plan covers Wegovy. Reduces your copay to as low as $0 for the first 3 months, then $25/month thereafter. Maximum savings of $500/fill. Not available for Medicare, Medicaid, or government-insured patients.
• NovoCare Patient Assistance Program: For uninsured patients who meet income eligibility criteria (typically ≤400% of federal poverty level). May provide Wegovy at no cost for qualifying patients.

Enroll at wegovy.com or by calling NovoCare at 1-888-809-3942.

Wegovy vs Ozempic vs Mounjaro: Insurance Coverage Compared